Trial Identifier: | ACE-CL-001 |
Sponsor: | AcertaPharma |
NCTID:: | NCT02029443 |
Start Date: | January 2014 |
Primary Completion Date: | July 2021 |
Study Completion Date: | July 2026 |
Condition: | CLL (Chronic Lymphocytic Leukemia) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version | |
Italian Version | |
English UK Translation |
Country | Location |
---|---|
GB | Leeds, GB, LS9 7TF |
GB | London, GB, SE5 9RS |
GB | Oxford, GB, OX3 7LE |
IT | Milano, IT, 20132 |
US, OH | Columbus, OH, US, 43210 |
US, MA | Boston, MA, US, 2215 |
US, NY | New Hyde Park, NY, US, 11042 |
US, NY | New York, NY, US, 10021 |
US, TX | Fort Worth, TX, US, 76104 |
US, UT | Salt Lake City, UT, US, 84112 |
US, WA | Seattle, WA, US, 98122 |
US, WA | Tacoma, WA, US, 98405 |